ANI PHARMACEUTICALS INC 4

Meredith Cook, SR. VP, General Counsel & Secretary of ANI Pharmaceuticals (ANIP), sold 500 shares of common stock at $75.48 per share under a Rule 10b5-1 plan.

On August 13, 2026, Meredith Cook, Senior Vice President, General Counsel & Secretary of ANI Pharmaceuticals, Inc., sold 500 shares of the company’s common stock at an average price of $75.48 per share, for total proceeds of approximately $37,740. This disposition was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 15, 2025. Following the sale, Cook continued to hold 74,424 shares of ANI Pharmaceuticals common stock, representing a substantial ongoing equity stake in the company.

Filing Facts

CIK

1023024

Ticker

ANIP

Form

4

Source Type

fda

Accession

0001938861-26-000023

Alert Tier

5